By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BrainStorm Cell Therapeutics Inc. 



Tel Aviv      Israel
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015 8:54:14 AM
BrainStorm Cell Therapeutics Inc. CEO To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:14:18 AM
BrainStorm Cell Therapeutics Inc. Announces Positive DSMB Recommendation In Ongoing Phase 2 Trial With NurOwn™ In ALS 2/3/2015 7:22:40 AM
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015 10:04:50 AM
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015 8:34:38 AM
BrainStorm Cell Therapeutics Inc. Announces Receipt Of Approximately $3.1 Million From Warrant Exercises 1/7/2015 9:09:19 AM
BrainStorm Cell Therapeutics Inc. Announces Final Analysis Of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit From NurOwn™ 1/5/2015 7:13:29 AM
BrainStorm Cell Therapeutics Inc. To Host Conference Call To Discuss Final Results Of Phase 2a Trial Of NurOwn™ In ALS On January 5, 2015 12/22/2014 9:20:08 AM
BrainStorm Cell Therapeutics Inc. Receives $1,100,000 For Its 8th Annual Non-Dilutive Grant From Israel's Chief Scientist Office 12/15/2014 8:28:20 AM
BrainStorm Cell Therapeutics Inc. Announces Financial Results For The Third Quarter Of 2014 And Provides Corporate Update 11/13/2014 9:08:21 AM
12345678910...
//-->